Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
drugs
3
×
life sciences
national blog main
national top stories
san diego blog main
3
×
san diego top stories
san francisco blog main
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
deals
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
startups
synthetic biology
teva pharmaceutical
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
acute myeloid leukemia
alder biopharmaceutical
allergan
american academy of neurology
What
drugs
3
×
drug
fda
new
advance
ahead
approval
arguments
asco
big
bio
biologic
biology
branded
choices
class
commercialized
commissioner
companies
competitors
consumers
costly
counterweight
cytokine
decades
demonstrating
diego’s
elevatebio
enhanced
generic
graft
lead
make
medications
meeting
migraine
neuro
oral
potential
produce
Language
Current search:
drugs
×
drugs
×
biotech
×
" san diego blog main "
×
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs
